Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.
N Engl J Med. 2013.
PMID: 23984728
Free article.
Clinical Trial.
Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension.
Khan A, White RJ, Meyer G, Pulido Zamudio TR, Jerjes-Sanchez C, Johnson D, Grover R, Broderick M, Ousmanou A, Holdstock L, Michelakis E.
Khan A, et al. Among authors: pulido zamudio tr.
Respir Med. 2022 Mar;193:106744. doi: 10.1016/j.rmed.2022.106744. Epub 2022 Jan 19.
Respir Med. 2022.
PMID: 35134631
Free PMC article.
Clinical Trial.
Item in Clipboard
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators.
Ghofrani HA, et al.
Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4.
Lancet Respir Med. 2024.
PMID: 38548406
Clinical Trial.
Item in Clipboard
Cite
Cite